Medicare Enrolled
Dr. Aniket Chakrabarti, M.D.
Internal Medicine · Pembroke, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chakrabarti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chakrabarti?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chakrabarti
Dr. Aniket Chakrabarti is an internal medicine specialist in Pembroke, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Chakrabarti performed 3,054 Medicare services across 1,128 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chakrabarti received a total of $27,739 from 89 pharmaceutical and/or device companies across 1564 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chakrabarti is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 6% volume in MA
$27,739 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,054
Medicare services
Top 6% in MA for internal medicine
1,128
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~161 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,480 | $94 | $330 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
415 | $55 | $250 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
351 | $8 | $10 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
150 | $40 | $100 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
143 | $42 | $110 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
119 | $135 | $251 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 62 | $20 | $35 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
62 | $34 | $65 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
61 | $27 | $100 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
54 | $33 | $65 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
47 | $39 | $130 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
37 | $3 | $12 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
34 | $117 | $375 |
| New patient office visit, complex (60-74 min) | 16 | $114 | $435 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $124 | $390 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
11 | $11 | $75 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$27,739
Total received (2018-2024)
Avg $3,963/year across 7 years
Top 7% in MA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
89
Companies
1,564
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$27,578 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$161 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,873
2023
$4,693
2022
$5,096
2021
$4,682
2020
$2,953
2019
$2,823
2018
$2,619
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$667
ABBVIE INC.
$301
Novo Nordisk Inc
$284
Abbott Laboratories
$281
Tolmar, Inc.
$243
ABIOMED
$215
Novartis Pharmaceuticals Corporation
$214
PFIZER INC.
$184
E.R. Squibb & Sons, L.L.C.
$181
Lilly USA, LLC
$173
Azurity Pharmaceuticals, Inc.
$173
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$170
Phathom Pharmaceuticals, Inc.
$166
Amgen Inc.
$147
Mannkind Corporation
$134
Inspire Medical Systems, Inc.
$119
Lundbeck LLC
$100
AIMMUNE THERAPEUTICS, INC.
$98
Otsuka America Pharmaceutical, Inc.
$90
Verity Pharmaceuticals Inc.
$88
Esperion Therapeutics, Inc.
$81
Medtronic, Inc.
$77
Bayer Healthcare Pharmaceuticals Inc.
$62
GlaxoSmithKline, LLC.
$58
Exact Sciences Corporation
$54
Alnylam Pharmaceuticals Inc.
$52
Sumitomo Pharma America, Inc.
$51
Takeda Pharmaceuticals U.S.A., Inc.
$47
Biogen, Inc.
$43
Antares Pharma, Inc.
$37
Xeris Pharmaceuticals, Inc.
$31
Dexcom, Inc.
$30
Optinose US, Inc.
$28
Axsome Therapeutics, Inc.
$25
IBSA Pharma Inc.
$25
Grifols USA, LLC
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
SANOFI-AVENTIS U.S. LLC
$23
Astellas Pharma US Inc
$23
Janssen Pharmaceuticals, Inc
$18
CeQur Corporation
$17
Lucid Diagnostics Inc.
$17
Top 3 companies account for 25.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,988
Novo Nordisk Inc
$1,787
PFIZER INC.
$1,535
Janssen Pharmaceuticals, Inc
$1,514
Abbott Laboratories
$1,233
Lilly USA, LLC
$1,134
Novartis Pharmaceuticals Corporation
$1,055
AbbVie Inc.
$947
ABBVIE INC.
$945
Amgen Inc.
$941
Takeda Pharmaceuticals U.S.A., Inc.
$857
Esperion Therapeutics, Inc.
$757
Allergan Inc.
$750
Boehringer Ingelheim Pharmaceuticals, Inc.
$684
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$657
ARBOR PHARMACEUTICALS, INC.
$569
Tolmar, Inc.
$526
E.R. Squibb & Sons, L.L.C.
$522
Allergan, Inc.
$504
Astellas Pharma US Inc
$456
Eisai Inc.
$401
Azurity Pharmaceuticals, Inc.
$401
Biohaven Pharmaceuticals, Inc.
$363
MannKind Corporation
$357
Avanir Pharmaceuticals, Inc.
$351
Nestle HealthCare Nutrition Inc.
$324
Lundbeck LLC
$276
Bayer Healthcare Pharmaceuticals Inc.
$255
Inspire Medical Systems, Inc.
$229
Axsome Therapeutics, Inc.
$228
Acerus Pharmaceuticals Corporation
$224
Arbor Pharmaceuticals, Inc.
$223
ABIOMED
$215
Merck Sharp & Dohme LLC
$213
Biohaven Pharmaceutical Holding Company Ltd.
$212
SANOFI-AVENTIS U.S. LLC
$200
Sunovion Pharmaceuticals Inc.
$199
Xeris Pharmaceuticals, Inc.
$192
Teva Pharmaceuticals USA, Inc.
$170
Otsuka America Pharmaceutical, Inc.
$167
Phathom Pharmaceuticals, Inc.
$166
Amarin Pharma Inc.
$152
Exact Sciences Corporation
$144
Mannkind Corporation
$134
Antares Pharma, Inc.
$131
Valeritas, Inc.
$129
Bayer HealthCare Pharmaceuticals Inc.
$109
IDORSIA PHARMACEUTICALS US INC
$100
Medtronic, Inc.
$99
Alkermes, Inc.
$99
AIMMUNE THERAPEUTICS, INC.
$98
Genentech USA, Inc.
$97
Merck Sharp & Dohme Corporation
$91
NESTLE HEALTHCARE NUTRITION INC.
$89
Verity Pharmaceuticals Inc.
$88
Shire North American Group Inc
$83
GlaxoSmithKline, LLC.
$82
Ironshore Pharmaceuticals Inc.
$81
ACADIA Pharmaceuticals Inc
$73
Biogen, Inc.
$73
Mylan Specialty L.P.
$72
Almatica Pharma LLC
$70
IBSA Pharma Inc.
$67
Regeneron Healthcare Solutions, Inc.
$65
Supernus Pharmaceuticals, Inc.
$64
ITI, Inc.
$58
Bausch Health US, LLC
$56
AbbVie, Inc.
$54
Alnylam Pharmaceuticals Inc.
$52
Sumitomo Pharma America, Inc.
$51
Dexcom, Inc.
$48
BioDelivery Sciences International, Inc.
$42
Horizon Therapeutics plc
$33
Kowa Pharmaceuticals America, Inc.
$32
OPKO Pharmaceuticals, LLC
$29
Optinose US, Inc.
$28
Nabriva Therapeutics, plc
$26
ANI Pharmaceuticals, Inc.
$25
Grifols USA, LLC
$25
Neurocrine Biosciences, Inc.
$21
Bardy Diagnostics, Inc.
$20
Shield Therapeutics Inc
$17
CeQur Corporation
$17
Lucid Diagnostics Inc.
$17
Collegium Pharmaceutical, Inc.
$17
Medtronic USA, Inc.
$16
Medtronic MiniMed, Inc.
$14
Scilex Pharmaceuticals Inc.
$14
MDD US Operations, LLC
$13
Top 3 companies account for 19.1% of all-time payments
Associated products mentioned in payments ›
ABILIFY MYCITE · ACCRUFER · ADUHELM · AFREZZA · AIRSUPRA · AJOVY · APLENZIN · APOKYN · APTIOM · ARISTADA · AUSTEDO · Adthyza · Aimovig · Auvelity · BAQSIMI · BASAGLAR · BELBUCA · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · BRINTELLIX · BUNAVAIL 2.1 mg 30-count box · BYSTOLIC · CAMZYOS · CAPLYTA · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CREON · Carnation Ambulatory Monitor · CeQur Simplicity · Cologuard Collection Kit · Creon · DEXCOM CGM · Dayvigo · Dexcom G6 Transmitter · EDARBI · ELIGARD · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FARXIGA · FASENRA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GEMTESA · GRALISE · GVOKE HYPOPEN · GVOKE PFS · HORIZANT · Horizant · INFINITY · INGREZZA · INPEN SMART INSULIN DELIVERY SYSTEM · INSPIRE · INTELLIS · INVOKANA · Impella · JANUVIA · JARDIANCE · JATENZO · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · KEVEYIS · KRYSTEXXA · KYNMOBI · Kerendia · LATUDA · LEQVIO · LINZESS · LOKELMA · LYRICA · LYUMJEV · Leqembi · Livalo · MAVYRET · MINIMED 780G · MOUNJARO · MYDAYIS · MYRBETRIQ · Minimed 670G System · Myrbetriq · NAPRELAN · NEXLETOL · NEXLIZET · NOCDURNA · NUCALA · NUEDEXTA · NUPLAZID · NURTEC ODT · Natesto · NovoLog · Nuedexta · OCREVUS · ONPATTRO · Otezla · Ozempic · PAXLOVID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Prolastin-C Liquid · Prolia · QULIPTA · QUVIVIQ · RAYALDEE · REXULTI · RYBELSUS · Repatha · Rybelsus · SIVEXTRO · SKYCLARYS · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · Saxenda · Sunosi · TLANDO · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TZIELD · Tirosint · Tlando · Tresiba · Trintellix · UBRELVY · V-GO · VIBERZI · VIIBRYD · VIVITROL · VOQUEZNA · VOWST · VRAYLAR · VYEPTI · VYVANSE · Vascepa · Veozah · Vivitrol 380 mg · Vyvanse · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xenleta · Xhance · Xtampza ER · Xtandi · Yupelri · ZENPEP · ZEPBOUND · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for internal medicine in MA.
Geographic Context
Internal medicine physicians within 10 mi
3,870
Per 100K population
727.6
County median income
$109,698
Nearest hospital
SIGNATURE HEALTHCARE BROCKTON HOSPITAL
10.0 mi
10.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chakrabarti is a clinical cardiology specialist, with above-average Medicare volume (top 6% in MA), with low-engagement industry engagement in the top 7% of MA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chakrabarti experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Chakrabarti performed 1,480 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chakrabarti receive payments from pharmaceutical companies?
Yes. Dr. Chakrabarti received a total of $27,739 from 89 companies across 1,564 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chakrabarti's costs compare to other internal medicine physicians in Pembroke?
Dr. Chakrabarti's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chakrabarti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Pembroke
Browse internal medicine physicians in Pembroke ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in MA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in MA
Which MA internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology